Am J Transplant, Volume 21, Suppl 3 Archives - Page 128 of 139 - ATC Abstracts

2021 American Transplant Congress
Sharing Under KAS – What is the Impact According to KDPI?
M. Jacobs, R. Stratta, C. Jay
Wake Forest Baptist Health, Winston Salem, NC
*Purpose: The new Kidney Allocation System (KAS) implemented in 2014 was designed to facilitate sharing of kidneys due to changes in prioritization of highly sensitized…
2021 American Transplant Congress
Donation After Cardiac Death (DCD) Agonal Phase Physiology is Associated with Post-transplant Kidney Graft Outcomes
A. Kayastha¹, K. C. Eddinger², E. M. Sonnenberg², N. Mahmud², D. E. Schaubel¹, P. L. Abt²
¹Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ²Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Kidneys procured from DCD donors play a key role in addressing the kidney shortage in the United States, and donor hemodynamics during obligatory warm…
2021 American Transplant Congress
Outcomes After Usage of Organs from Deceased Organ Donors with Sepsis – A Single-center Experience
A. Sharma¹, D. Choudhary¹, D. Kenwar¹, S. Singh¹, S. kumar¹, K. jain², N. Bansal³, A. Ravi¹
¹Renal & Pancreas Transplant Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India, ²Anesthesiology, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India, ³Transplant Coordinator, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India
*Purpose: The deceased Organ Donation rate is around 0.8/million in our nation. There remains a severe shortage of organs worldwide, leading to a trend towards…
2021 American Transplant Congress
Current Opioid Utilization Practices of Kidney Transplant Centers in the United States: A National Survey of Institutional Practices
A. Lichvar¹, H. Kim¹, A. Ingemi², J. Jarrett¹
¹University of Illinois at Chicago, Chicago, IL, ²Sentara Healthcare, Norfolk, VA
*Purpose: The opioid epidemic in the United States (US) and the known risks of opioid utilization highlight the need for better understanding of pain management…
2021 American Transplant Congress
Role of Serial Donor Derived Cell-Free DNA Monitoring in Kidney Transplant Recipients
A. X. Wang, C. R. Lenihan
Nephrology, Stanford University School of Medicine, Palo Alto, CA
*Purpose: Donor derived cell-free DNA (dd cf-DNA; Allosure, CareDx) is increasingly employed for non-invasive kidney transplant monitoring. The goal of this study was 1) to…
2021 American Transplant Congress
Dietary Intake of Calories and Protein in the Acute Phase Following Kidney Transplant: Opportunities for Improvement
L. Teigen¹, G. Onyeaghala¹, Y. Doronin², B. Guo¹, B. Wu¹, J. Abrahante¹, D. Schladt¹, W. Guan¹, C. Staley¹, M. Al-Kofahi¹, S. Riad¹, A. Matas¹, R. Remmel¹, W. Oetting¹, C. Dorr¹, P. Jacobson¹, A. Israni¹
¹University of Minnesota, Minneapolis, MN, ²Hennepin Healthcare Research Institute, Minneapolis, MN
*Purpose: Nutritional therapy post kidney transplant includes both an acute (1-1.5 months post-transplant) and a chronic phase. To date, most of the available literature has…
2021 American Transplant Congress
Outcomes of Second Kidney Transplant After Return to Dialysis by Induction Type in the United States
S. Riad¹, T. Shaker¹, S. Jackson², R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, M-Health Fairview, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: A failed kidney allograft is the 4th leading indication for kidney transplantation. We examined the association of induction use in 2nd kidney transplant recipients…
2021 American Transplant Congress
Evaluation of Empiric Extended-Release Tacrolimus Dosing in Adult Kidney Transplant Recipients
C. Patel, S. Lee, D. M. Salerno, N. W. Lange, J. Hedvat
Pharmacy, NewYork-Presbyterian Hospital, New York, NY
*Purpose: Envarsus XR® (extended-release [XR] tacrolimus) is the standard of care tacrolimus formulation at our center for de novo maintenance immunosuppression in adult kidney transplant…
2021 American Transplant Congress
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
T. Yagisawa¹, T. Kanzawa¹, K. Unagami², M. Furusawa¹, M. Inui¹, H. Ishida², K. Tanabe¹
¹Department of Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Development of de novo donor-specific anti-HLA antibodies (dnDSA) after kidney transplantation remains strongly associated with antibody-mediated rejection (AMR), which leads to poor graft outcome.…
2021 American Transplant Congress
Preempting Misconceptions: An Educational Initiative for Preemptive Kidney Transplant Candidates
T. Menser¹, M. Hobeika², H. Ibrahim², A. Khan¹, B. Cruz², J. Sharp², A. Gaber²
¹Houston Methodist Research Institute, Houston, TX, ²Houston Methodist Hospital, Houston, TX
*Purpose: reemptive living donor kidney transplantation (pLDKT) offers many advantages for patients with advanced chronic kidney disease. However, pLDKT represents less than 1 out of…